Literature DB >> 15260106

Modulatory effect of diclofenac on antispasmodic effect of pitofenone in cholinergic spasm.

Shrinivas K Kulkarni1, Chandrashekhar S Patil, Naveen K Jain, Amarjit Singh.   

Abstract

Biliary, ureteric and intestinal colic are extremely common clinical conditions associated with smooth muscle spasm. In the present study, antispasmodic activity was carried out against acetylcholine (10-640 ng/ml)-induced contractions on guinea pig ileum. Acetylcholine (10-640 ng/ml) induced concentration-dependent contraction of smooth muscle. Diclofenac, in varying concentration (9.4 x 10(-5) mol/l and 14.1 x 10(-5) mol/l) shifted the concentration response curve of acetylcholine to the right without suppressing the maximal response. However, in higher concentration diclofenac (18.9 x 10(-5) mol/l) blocked the response in an unsurmountable fashion. Further, analgin (11.09 x 10(-5), 16.63 x 10(-5) and 22.18 x 10(-5) mol/l) in equimolar concentrations did not alter the concentration response curve of acetylcholine, but in higher concentration analgin (44.36 x 10(-5) mol/l) also blocked the response in an unsurmountable fashion. Pitofenone (2.5 x 10(-6) mol/l) also, shifted the concentration response curve of acetylcholine to right in a parallel fashion with no change in maximal response. The present study confirms the potent antispasmodic activity of diclofenac-pitofenone combination in comparison to analgin-pitofenone in molar equivalent concentration (in comparison to diclofenac) against acetylcholine-induced contractions of guinea pig ileum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15260106

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  2 in total

1.  Drug management of visceral pain: concepts from basic research.

Authors:  Mellar P Davis
Journal:  Pain Res Treat       Date:  2012-04-24

2.  Synthesis of hydrazides of heterocyclic amines and their antimicrobial and spasmolytic activity.

Authors:  Dmitriy A Berillo; Moldyr A Dyusebaeva
Journal:  Saudi Pharm J       Date:  2022-04-26       Impact factor: 4.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.